Nilandron
Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.
What Nilandron Means in Everyday Medical Language
Nilandron is a brand name for the drug nilutamide, which is used to treat prostate cancer that has spread to other parts of the body. It belongs to a group of medicines called nonsteroidal antiandrogens. These drugs work by blocking androgen receptors—proteins found on some prostate cancer cells that respond to male hormones like testosterone. Since these hormones can encourage cancer cells to grow, blocking their effects may help slow the cancer’s progress.
Why Nilandron Can Matter in Cancer Care
Prostate cancer often depends on male hormones to grow. Treatments that lower hormone levels or block their effects are common in managing advanced prostate cancer. Nilandron is used alongside other hormone therapies, such as gonadotropin-releasing hormone (GnRH) analogues, to prevent a temporary rise in testosterone called a testosterone flare. This flare can happen when starting GnRH therapy and might temporarily worsen symptoms. By blocking androgen receptors, Nilandron helps reduce this risk and supports hormone therapy’s effectiveness.
What Patients Might See or Be Told About Nilandron
Patients may hear the names Nilandron or nilutamide used interchangeably. It is important to recognize these are the same medicine. Nilandron is usually taken by mouth in tablet form, starting with a higher dose for the first month and then lowering. Side effects can include breast tenderness or enlargement, hot flashes, nausea, and sometimes changes in vision or liver function. Because of these possible effects, doctors monitor patients closely during treatment. Patients might also hear about Nilandron in the context of preventing testosterone flare when starting hormone therapy.
Where the Term Nilandron Might Appear
You may see Nilandron mentioned in your medical records, treatment plans, or medication lists. It can also appear on clinical trial pages or drug information websites. Since the drug is sold under different brand names worldwide, comparing the exact spelling or name in your documents can help avoid confusion. Your healthcare team can clarify if you are unsure whether Nilandron or nilutamide is part of your treatment.
Common Sources of Confusion and How to Understand Nilandron
Nilandron is sometimes confused with other antiandrogen drugs because several medicines block male hormones in prostate cancer treatment. It is a first-generation antiandrogen, and newer drugs with similar actions but different side effect profiles also exist. Knowing that Nilandron is often combined with other hormone therapies helps understand its role. Also, it is not usually used alone but as part of a combined approach to hormone therapy.
Questions to Ask Your Care Team About Nilandron
If Nilandron is part of your treatment, you might ask your doctor how it works with other therapies, what side effects to watch for, and how it will be monitored. You can also ask about the reasons for choosing this drug over others and what to expect during treatment. Understanding how Nilandron fits into your overall care plan can help you feel more informed and involved.
Safety and Context for Using This Information
This information is meant to help you understand what Nilandron is and how it may be used in prostate cancer treatment. It does not replace medical advice or decisions made by your healthcare team. Side effects and treatment responses vary between individuals. Always discuss your specific situation, treatment options, and concerns with your doctor or nurse.
Next Steps for Patients Learning About Nilandron
If you see the term Nilandron or nilutamide in your medical records or hear it mentioned by your care team, the best next step is to ask for clear explanations about how it relates to your treatment. Knowing what to expect and how it fits into your care can help you feel more confident and prepared. Your healthcare providers are there to support you and answer your questions about this medication and your cancer journey.
Sources
Public source information used for this glossary entry includes: